Drug Discovery & Development Insights by OmicsX
No Result
View All Result
  • Login
  • Register
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
PRICING
SUBSCRIBE
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
No Result
View All Result
Drug Discovery & Development Insights by OmicsX
No Result
View All Result

BiG Pharma – Oncology Insights & Updates

BiG Pharma - Oncology Insights & Updates

May 28, 2022
Reading Time: 1 min read
A A
Home Big Pharma

Top 15 Pharma Companies alone comprise of more than 10% of Oncology Drug Development worldwide.

RELATED POSTS

Takeda Oncology –
Deals and Alliances Insights

Takeda Oncology-
Drug Pipeline Insights – June 2021

Boehringer Ingelheim GmbH –
Oncology Drug Pipeline Insights – June 2021

Global Oncology Intelligence Global Oncology Intelligence Global Oncology Intelligence

 

Share196Tweet123SendShare34
Previous Post

Targeted Cancer Therapies – Antibodies

 Next Post

Small Molecule Kinase Inhibitors – Clinical Drug Developers

Related Posts

Takeda Oncology –Deals and Alliances Insights
Big Pharma

Takeda Oncology –
Deals and Alliances Insights

May 30, 2022
Takeda Oncology- Drug Pipeline Insights – June 2021
Big Pharma

Takeda Oncology-
Drug Pipeline Insights – June 2021

May 30, 2022
Gilead Sciences, Inc. – Oncology Deals and Alliances Insights
Big Pharma

Boehringer Ingelheim GmbH –
Oncology Drug Pipeline Insights – June 2021

May 30, 2022
GlaxoSmithKline plc. – Oncology Drug Pipeline Insights – June 2021
Big Pharma

GlaxoSmithKline plc. –
Oncology Drug Pipeline Insights – June 2021

May 30, 2022
GlaxoSmithKline plc. – Oncology Deals and Alliances Insights
Big Pharma

GlaxoSmithKline plc. –
Oncology Deals and Alliances Insights

May 30, 2022
Gilead Sciences, Inc. – Oncology Drug Pipeline Insights – June 2021
Big Pharma

Gilead Sciences, Inc. –
Oncology Drug Pipeline Insights – June 2021

May 30, 2022
Next Post

Small Molecule Kinase Inhibitors – Clinical Drug Developers

Kinase Inhibitors - An Overview

Categories

  • Antibodies
  • Antibody Drug Conjugate
  • Big Pharma
  • Bio Partnering
  • Bispecific Antibody
  • Cell Therapy
  • Channels
  • Company Profiles
  • Deals & Collaborations (BP)
  • Drug Targets
  • Epigenetic
  • ImmunoOncology
  • Investments & Deals
  • Kinase
  • Microbiome
  • Monoclonal Antibodies
  • Neurology
  • Onco Deals / Alliances
  • Onco Pipeline Insights (BP)
  • Oncology
  • Oncolytic Viruses
  • Pipeline
  • Small Molecules
  • Startups
  • Uncategorized
Emerging Drug Developers Developing Cancer Targeting Exosomes
Startups

Emerging Drug Developers Developing Cancer Targeting Exosomes

by Team OmicsX
July 10, 2022
0

Exosomes are cell-derived nanovesicles, which are usually 50-150 nm in diameter and are involved in the intercellular transportation of materials....

Read more
Cancer Microbiome Targeting Emerging Drug Developers

Cancer Microbiome Targeting Emerging Drug Developers

July 9, 2022
Antibody Drug Conjugates

Antibody Drug Conjugates

June 18, 2022
Oncolytic Viruses

Oncolytic Viruses

June 29, 2022
Bispecific Antibodies

Bispecific Antibodies

June 14, 2022
Drug Discovery & Development Insights by OmicsX

Mapping Bio-Innovations

updated.. easy.. precise... complete...

Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.

LEARN MORE »

  • Trending
  • Comments
  • Latest
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

May 30, 2022
Approved Oncology Targeting Small Molecule Kinase Inhibitors

Approved Oncology Targeting Small Molecule Kinase Inhibitors

May 30, 2022

Kinase Inhibitors in Preclinical Development – 2021

May 30, 2022

Small Molecule Kinase Inhibitors – Preclinical Drug Developers

June 1, 2022

Small Molecule Kinase Inhibitors – Preclinical Drug Developers

0
Hoffmann-La Roche – Oncology Drug Pipeline Insights – June 2021

Hoffmann-La Roche –
Oncology Drug Pipeline Insights – June 2021

0
AbbVie, Inc. – Oncology Drug Pipeline Insights – June 2021

AbbVie, Inc. –
Oncology Drug Pipeline Insights – June 2021

0
Amgen, Inc. Oncology Drug Pipeline Analysis – June 2021

Amgen, Inc.
Oncology Drug Pipeline Analysis – June 2021

0
Emerging Drug Developers Developing Cancer Targeting Exosomes

Emerging Drug Developers Developing Cancer Targeting Exosomes

July 10, 2022
Cancer Microbiome Targeting Emerging Drug Developers

Cancer Microbiome Targeting Emerging Drug Developers

July 9, 2022
Antibody Drug Conjugates

Antibody Drug Conjugates

June 18, 2022
Oncolytic Viruses

Oncolytic Viruses

June 29, 2022

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

No Result
View All Result
  • Home
  • Subscription
  • Category
    • Opinion
    • Tech
  • Landing Page
  • Buy JNews
  • Support Forum
  • Pre-sale Question
  • Contact Us

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?